Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03274037 : Evaluation of Cerebral Elastography by Magnetic Resonance: Comparison of Healthy Subjects and Patients With Glial Tumor
AgesMin: 18 Years Max: 65 Years
Inclusion Criteria for healthy subjects will be:

- Age between 18 and 65 years

- Ability to hold in an MRI device without moving

- No known and diagnosed neurological pathologies such as stroke, cerebral surgery,
central nervous system tumor, inflammatory disease (such as multiple sclerosis),
neurodegenerative disease (such as Alzheimer's, Parkinson's or Creutzfeldt-Jakobes's
), depression

- Informed consent

Inclusion criteria for patients will be:

- Age between 18 and 65 years

- Ability to hold in an MRI device without moving

- Glial tumor greater than 3 mm diagnosed by standard MRI

- Informed and informed consent

Exclusion Criteriafor both patients and healthy subjects will be:

- Inability to perform an MRI examination : claustrophobia, presence of ferromagnetic
metallic foreign bodies, wearing a pace-maker, metallic cardiac prosthetic valve,
cochlear implants, vascular clips, insulin pump, pregnancy, breastfeeding..

- Non-affiliation to a social security scheme (beneficiary or beneficiary)

- Intercurrent disorder likely to disrupt test results

- Patient under anticoagulant:
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557